Sarepta Therapeutics to Present Company Overview at the 2012

Sarepta Therapeutics to Present Company Overview at the 2012 Lazard
Capital Markets 9th Annual Healthcare Conference 
Webcast Accessible via Sarepta Therapeutics Website 
CAMBRIDGE, MA -- (Marketwire) -- 11/06/12 --   Sarepta Therapeutics
(NASDAQ: SRPT), a developer of innovative RNA-based therapeutics,
announced today that it is scheduled to present at the 2012 Lazard
Capital Markets 9th Annual Healthcare Conference in New York, NY on
Tuesday, November 13, 2012 at 4:30 p.m. Eastern Time. Chris
Garabedian, Sarepta's president and CEO, will be the presenter. 
The presentation will be webcast live under the events section of
Sarepta Therapeutics' website at www.sareptatherapeutics.com and will
be archived there following the presentation for 90 days. Please
connect to Sarepta's website several minutes prior to the start of
the broadcast to ensure adequate time for any software download that
may be necessary. 
About Sarepta Therapeutics 
Sarepta Therapeutics is focused on developing first-in-class
RNA-based therapeutics to improve and save the lives of people
affected by serious and life-threatening rare and infectious
diseases. The Company's diverse pipeline includes its lead program
eteplirsen, for Duchenne muscular dystrophy, as well as potential
treatments for some of the world's most lethal infectious diseases.
Sarepta aims to build a leading, independent biotech company
dedicated to translating its RNA-based science into transformational
therapeutics for patients who face significant unmet medical needs.
For more information, please visit us at www.sareptatherapeutics.com. 
Sarepta Media and Investor Contact: 
Erin Cox 
425.354.5140 
ecox@sareptatherapeutics.com 
 
 
Press spacebar to pause and continue. Press esc to stop.